WebDrug Name: BMS-986315: Trade Name: Synonyms: BMS 986315 BMS986315: Drug Descriptions: BMS-986315 is a monoclonal antibody that binds to NKG2A and prevents its interaction with HLA-E, which may lead to cytotoxic immune response against tumor cells (NCI Thesaurus). ... BMS-986315 Cetuximab 0: 1: BMS-986315 + Nivolumab Generic name: cetuximab [ se-TUX-i-mab ] Brand name: Erbitux. Dosage form: intravenous solution (2 mg/mL) Drug class: EGFR inhibitors. Medically reviewed by Drugs.com on Jan 24, 2024. Written by Cerner Multum. Uses. Warnings. Before taking. See more Cetuximab is used to treat cancers of the colon and rectum. It is also used to treat head and neck cancer. Cetuximab may also be used for purposes not listed in this medication guide. See more Cetuximab is given as an infusion into a vein. A healthcare provider will give you this injection. cetuximab must be given slowly, and the infusion can take up to 2 hours to complete. You may be given other medications to … See more Cetuximab has caused life-threatening side effects in a small number of patients.Your caregivers will watch you closely after you … See more You should not use this medicine if you are allergic to cetuximab or to mouse protein. Tell your doctor if you have ever had: 1. heart rhythm … See more
Cetuximab - Drug Information - Chemocare
WebSTAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients. Cancer Immunol Res. 2015;3:936-45. WebImClone, in collaboration with licensees, Merck KGaA and Bristol-Myers Squibb (BMS), are developing cetuximab, a chimeric monoclonal antibody that blocks the epidermal … alanvale tastafe campus
Cetuximab Uses, Side Effects & Warnings - Drugs.com
WebErbitux® GCTS Formulation . Synonyms: C225; BMS 564717; Cetuximab; Anti-EGFr Chimeric Monoclonal Antibody in European Formulation . Product Uses: Drug used for the treatment of cancer . 1.2. Company Information . Company Name / Address: ImClone Systems, A wholly-owned subsidiary of Eli Lilly and Company WebDrug type: Cetuximab is an anti-cancer ("anti-neoplastic") targeted therapy. This medication is classified as a "monoclonal antibody" and "Epidermal Growth Factor Receptor … WebFeb 13, 2004 · Erbitux is the first approved drug made by ImClone, a 20-year-old New York company that should finally become profitable. The approval entitles it to a $250 million payment from Bristol-Myers as ... alan vicenzo emir boscatto gustavo cruz